Reaction
Throat Cancer reporting signals
As of the last recalculation, Throat Cancer appears in 4,197 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is RANITIDINE HYDROCHLORIDE (PRR 32.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranitidine Hydrochloride | 329 | 32.5 | 32.7 |
| Ranitidine | 633 | 18.4 | 18.5 |
| Nicotine Polacrilex Mini | 14 | 4.6 | 4.6 |
| Nicotine Polarilex | 14 | 4.6 | 4.6 |
| Tiotropium Bromide Inhalation Spray | 9 | 4.0 | 4.0 |
| Sulfasalazine | 56 | 3.6 | 3.6 |
| Icosapent Ethyl | 6 | 3.5 | 3.5 |
| Umeclidinium | 6 | 3.3 | 3.3 |
| Umeclidinium Bromide And Vilanterol Trifenatate | 10 | 3.0 | 3.0 |
| Ranolazine | 6 | 2.9 | 2.9 |
| Nicotine | 23 | 2.8 | 2.8 |
| Fluticasone Propionate And Salmeterol | 23 | 2.7 | 2.7 |
| Risankizumab-Rzaa | 44 | 2.7 | 2.7 |
| Nicotine Polacrilex | 20 | 2.6 | 2.6 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 5 | 2.4 | 2.4 |
| Dofetilide | 5 | 2.4 | 2.4 |
| Rifaximin | 8 | 1.9 | 1.9 |
| Benralizumab | 7 | 1.7 | 1.7 |
| Pirfenidone | 14 | 1.7 | 1.7 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 6 | 1.6 | 1.6 |
| Acalabrutinib | 4 | 1.6 | 1.6 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 13 | 1.6 | 1.6 |
| Sacubitril And Valsartan | 33 | 1.4 | 1.4 |
| Varenicline Tartrate | 22 | 1.4 | 1.4 |
| Glecaprevir And Pibrentasvir | 3 | 1.4 | 1.4 |
| Oxymorphone Hydrochloride | 3 | 1.3 | 1.3 |
| Patiromer | 3 | 1.1 | 1.1 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 5 | 0.8 | 0.8 |